182 related articles for article (PubMed ID: 35243423)
1. Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis.
Hendrikson J; Liu Y; Ng WH; Lee JY; Lim AH; Loh JW; Ng CCY; Ong WS; Tan JW; Tan QX; Ng G; Shannon NB; Lim WK; Lim TKH; Chua C; Wong JSM; Tan GHC; So JBY; Yeoh KG; Teh BT; Chia CS; Soo KC; Kon OL; Tan IB; Chan JY; Teo MCC; Ong CJ;
Cell Rep Med; 2022 Feb; 3(2):100526. PubMed ID: 35243423
[TBL] [Abstract][Full Text] [Related]
2. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.
Peng Y; Kajiyama H; Yuan H; Nakamura K; Yoshihara M; Yokoi A; Fujikake K; Yasui H; Yoshikawa N; Suzuki S; Senga T; Shibata K; Kikkawa F
Cancer Lett; 2019 Feb; 442():181-192. PubMed ID: 30429105
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
[TBL] [Abstract][Full Text] [Related]
4. The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer.
Chambers SK; Gertz RE; Ivins CM; Kacinski BM
Cancer; 1995 Apr; 75(7):1627-33. PubMed ID: 8826920
[TBL] [Abstract][Full Text] [Related]
5. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Zhao L; Yasumoto K; Kawashima A; Nakagawa T; Takeuchi S; Yamada T; Matsumoto K; Yonekura K; Yoshie O; Yano S
Cancer Sci; 2013 Dec; 104(12):1640-6. PubMed ID: 24118504
[TBL] [Abstract][Full Text] [Related]
6. Generating patient-derived ascites-dependent xenograft mouse models of peritoneal carcinomatosis.
Liu Y; Ng WH; Zhu HY; Tan QX; Hendrikson J; Tan JW; Ng G; Lim WK; Ong CJ
STAR Protoc; 2022 Sep; 3(3):101548. PubMed ID: 35842864
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
8. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
9. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery.
Shimomura M; Hinoi T; Ikeda S; Adachi T; Kawaguchi Y; Tokunaga M; Sasada T; Egi H; Tanabe K; Okajima M; Ohdan H
Surgery; 2013 Mar; 153(3):344-56. PubMed ID: 23218127
[TBL] [Abstract][Full Text] [Related]
10. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
11. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
[TBL] [Abstract][Full Text] [Related]
12. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells.
Wei M; Yang T; Chen X; Wu Y; Deng X; He W; Yang J; Wang Z
Oncotarget; 2017 Jun; 8(26):42262-42271. PubMed ID: 28178689
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis.
Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560
[TBL] [Abstract][Full Text] [Related]
15. Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer.
Wen W; Liang W; Wu J; Kowolik CM; Buettner R; Scuto A; Hsieh MY; Hong H; Brown CE; Forman SJ; Horne D; Morgan R; Wakabayashi M; Dellinger TH; Han ES; Yim JH; Jove R
Mol Cancer Ther; 2014 Dec; 13(12):3037-48. PubMed ID: 25319391
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxidized regenerated cellulose (Interceed) on the expression of tissue plasminogen activator and plasminogen activator inhibitor-1 in human peritoneal fibroblasts and mesothelial cells.
Gago LA; Saed G; Elhammady E; Diamond MP
Fertil Steril; 2006 Oct; 86(4 Suppl):1223-7. PubMed ID: 17008148
[TBL] [Abstract][Full Text] [Related]
17. Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?
Barreto DL; Coester AM; Struijk DG; Krediet RT
Perit Dial Int; 2013; 33(5):529-37. PubMed ID: 23994841
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.
Honjo K; Munakata S; Tashiro Y; Salama Y; Shimazu H; Eiamboonsert S; Dhahri D; Ichimura A; Dan T; Miyata T; Takeda K; Sakamoto K; Hattori K; Heissig B
FASEB J; 2017 Jun; 31(6):2625-2637. PubMed ID: 28270519
[TBL] [Abstract][Full Text] [Related]
20. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
